November 18, 2026
Health news, explained with evidence
LIVE

Intensive Blood Pressure Reduction Lowers Future Cardiovascular Risk After Stroke, Study Finds

🧠 AI Analysis 2 min read 👁 2

A multicenter trial presented at the American Heart Association Scientific Sessions suggests that maintaining a systolic blood pressure below 120 mmHg reduces major cardiovascular events in adults with a history of ischemic stroke or transient ischemic attack.

Intensive Blood Pressure Reduction Lowers Future Cardiovascular Risk After Stroke, Study Finds🧠AI Analysis

Photo: Medical Xpress

Key points

  • Targeting a systolic blood pressure below 120 mmHg reduced major cardiovascular events compared to a target below 140 mmHg.
  • The multicenter, randomized trial followed participants for a median of 3.9 years.
  • Intensive treatment was linked to a higher frequency of adverse renal outcomes, requiring close monitoring.

A recent clinical study indicates that more aggressive management of systolic blood pressure significantly decreases the occurrence of major cardiovascular events in patients who have previously experienced an ischemic stroke or transient ischemic attack. Published in the New England Journal of Medicine and presented at the American Heart Association Scientific Sessions in Chicago, the research evaluated whether a target below 120 mmHg offers better protection than the traditional target below 140 mmHg.

Led by Dr. Gisele Sampaio Silva from the Hospital Israelita Albert Einstein in São Paulo, Brazil, along with fellow researchers, the multicenter trial enrolled thousands of participants across 30 sites. Patients were randomly assigned to either an intensive treatment group aiming for a systolic reading under 120 mmHg or a standard treatment group aiming for under 140 mmHg. Over a median follow-up period of nearly four years, the primary composite outcome—which included cardiovascular death, nonfatal stroke, nonfatal myocardial infarction, and hospitalization for heart failure or unstable angina—was observed in 10.9 percent of the intensive-treatment cohort compared to 13.5 percent of the standard-treatment cohort.

However, the trial also revealed potential trade-offs associated with stricter blood pressure control. Researchers noted that a composite renal outcome involving significant declines in kidney function occurred more frequently among participants receiving intensive treatment, though the overall incidence of serious adverse events remained comparable between both groups.

What to know: While aggressive blood pressure lowering may reduce subsequent cardiovascular complications following a stroke, it requires careful clinical oversight and regular monitoring of renal health. Patients should consult a healthcare professional before making any changes to their medical regimen or blood pressure targets.

Source Medical Xpress — medicalxpress.com/news/2026-11-aha-intensive-blood-pressure-lowering.ht… ↗

Contact the newsroom

Got a tip, a proposal or a partnership question? Write to us and we will reply shortly.